.png)
.png)
Research Scientist
MD Anderson UT
Disclosure(s): No financial relationships to disclose
My name is Bahgat Zakaria Youssef Gerges (Bahgat Gerges), I graduated for PhD in Public Health, Majoring in Microbiology., Grade Excellent with Honor in 1999, Master Degree in Public Health Grade Received Excellent with Honor in 1988.and Bachelor of Veterinary Science. in 1983.
I'm a Research Scientist at MD Anderson, UT.
Her's some of the recent bubications:
Enhanced Biofilm Eradication and Reduced Cytotoxicity of a Novel Polygalacturonic and Caprylic Acid Wound Ointment Compared with Common Antiseptic Ointments
-The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review
-Assessment of Biofilm Eradication and Cytotoxicity of a Novel Polygalacturonic Acid + Caprylic Acid Wound Ointment Compared with Antiseptic Wound Ointments
Bahgat Gerges, PhD,1 Ruth A Reitzel, PhD,1 Joel Rosenblatt, PhD,1 Ray Y Hachem, MD,2 and Issam I Raad, MD3
Infect Dis. 2019 Oct; 6(Suppl 2): S311.
-In vitro Activity of Cefiderocol and Comparator Agents against Gram-Negative Isolates from Cancer Patients
Infect Dis. 2018 Nov; 5(Suppl 1): S421–S422.
Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations
-Erratum for Reitzel et al., “Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective In Vitro for Eradication of Candida auris Biofilms”
-Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective In Vitro for Eradication of Candida auris Biofilms
Antimicrob Agents Chemother. 2020 Apr; 64(4): e02146-19.
-Minocycline EDTA Ethanol (MEDTA+EtOH) Lock Is Highly Efficacious in Rapidly Eradicating Candida auris Biofilm
Infect Dis. 2019 Oct; 6(Suppl 2): S416.
-Review of allergic reactions from use of chlorhexidine on medical products in clinical settings over 40 years: Risks and mitigations
Infect Control Hosp Epidemiol . 2021 Jun 3;1-15. doi: 10.1017/ice.2021.150.